MedTrace Logo

Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent

NCT01512563 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2020-03-11

No results posted yet for this study

Summary

Paclitaxel covered metal biliary stent extents their patency rate comparing to the Common Covered Metallic Biliary Stent.

Conditions

  • Biliary Stricture
  • Malignant Neoplasms

Interventions

DEVICE

Biliary stent

palliative treatment for malignant patients

Sponsors & Collaborators

  • Taewoong Medical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Dong Ki Lee, Ph.D · Kangnam Severance Hospital

  • Ho Gak Kim · Catholic University of Daegu School of Medicine

  • Sang Heum Park · Soon Chun Hyang University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01512563 on ClinicalTrials.gov